Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.55 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | NCF1 | P14598 | 2/20 | 0.50 |
| ▸ | NOS2 | P35228 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3267444 | 0.98 | CYSLTR1 (0.57) | CYSLTR1CYSLTR2LMNACYP1A2NCF1 | |
| SCHEMBL30879956 | 0.98 | CYSLTR1 (0.57) | CYSLTR1CYSLTR2LMNACYP1A2NCF1 | |
| SCHEMBL26911035 | 0.87 | CYSLTR1 (0.53) | CYSLTR1CYSLTR2LMNACYP1A2NCF1 | |
| SCHEMBL3253637 | 0.85 | CYSLTR1 (0.55) | CYSLTR1CYSLTR2LMNACYP1A2NCF1 | |
| SCHEMBL1568267 | 0.84 | SMN1; SMN2 (0.57) | CYSLTR1CYSLTR2LMNACYP1A2PDE10A | |
| SCHEMBL2913941 | 0.83 | PDE10A (0.61) | CYSLTR1CYSLTR2CYP1A2NCF1NOS2 | |
| Hydrochloric Acid SCHEMBL27514003 | 0.83 | CYSLTR1 (0.53) | CYSLTR1CYSLTR2LMNACYP1A2NCF1 | |
| SCHEMBL29035750 | 0.83 | CYSLTR1 (0.53) | CYSLTR1CYSLTR2LMNACYP1A2NCF1 | |
| SCHEMBL21499258 | 0.82 | CYP1A2 (0.50) | CYSLTR1CYSLTR2LMNACYP1A2NCF1 | |
| SCHEMBL7972071 | 0.82 | CYSLTR1 (0.45) | CYSLTR1CYSLTR2LMNACYP1A2NCF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7329466-B2 | Organic element for electroluminescent devices | EASTMAN KODAK COMPANY (US) | 2008-02-12 | — | — | US | disclosed |
| US-20060210829-A9 | Organic element for electroluminescent devices | EASTMAN KODAK COMPANY | 2006-09-21 | — | — | US | disclosed |
| WO-2005076385-A1 | A BIS(AZINYL) METHENE BORON COMPLEX USED AS AN EMISSIVE DOPANT IN AN ORGANIC LIGHT EMITTING DEVICE | EASTMAN KODAK COMPANY (US) | 2005-08-18 | — | — | WO | disclosed |
| US-20050170204-A1 | Organic element for electroluminescent devices | EASTMAN KODAK COMPANY | 2005-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060210829-A9 | Organic element for electroluminescent devices | EED, JUND, OCIAD2 | CYSLTR1 2530/4885CYSLTR2 1318/4885LMNA 1419/4885 |
| US-20050170204-A1 | Organic element for electroluminescent devices | EED, JUND, OCIAD2 | CYSLTR1 2530/4885CYSLTR2 1318/4885LMNA 1419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.